Senseonics (NYSE:SENS) Raised to Strong-Buy at Mizuho

Senseonics (NYSE:SENS) was upgraded by analysts at Mizuho to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports.

Several other analysts also recently commented on the stock. StockNews.com assumed coverage on shares of Senseonics in a research report on Thursday, December 26th. They set a “sell” rating on the stock. HC Wainwright reissued a “buy” rating and set a $2.00 price target on shares of Senseonics in a research report on Wednesday, March 5th.

Senseonics Stock Up 0.7 %

Shares of SENS stock traded up $0.00 during trading hours on Wednesday, hitting $0.58. 310,707 shares of the company’s stock traded hands, compared to its average volume of 6,269,748. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. The stock’s fifty day simple moving average is $0.79 and its two-hundred day simple moving average is $0.58. Senseonics has a 12-month low of $0.25 and a 12-month high of $1.40. The stock has a market cap of $374.81 million, a price-to-earnings ratio of -4.43 and a beta of 0.84.

Senseonics (NYSE:SENS) last announced its quarterly earnings data on Monday, March 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same period in the previous year, the firm posted ($0.07) EPS. On average, analysts expect that Senseonics will post -0.14 EPS for the current year.

Institutional Investors Weigh In On Senseonics

Several institutional investors have recently modified their holdings of SENS. First Light Asset Management LLC bought a new position in Senseonics during the 4th quarter valued at about $3,366,000. Geode Capital Management LLC raised its holdings in shares of Senseonics by 9.7% during the fourth quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company’s stock valued at $3,354,000 after purchasing an additional 566,704 shares during the last quarter. Jane Street Group LLC lifted its position in Senseonics by 6,694.1% during the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company’s stock valued at $3,203,000 after purchasing an additional 6,028,726 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in Senseonics by 9.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,339,698 shares of the company’s stock worth $1,748,000 after purchasing an additional 274,842 shares during the last quarter. Finally, Renaissance Technologies LLC bought a new stake in Senseonics in the 4th quarter worth approximately $720,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.